Premium
Transcatheter treatment of aortic regurgitation: Still enigmatic
Author(s) -
Block Peter C.
Publication year - 2018
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.27652
Subject(s) - medicine , regurgitation (circulation) , cardiology , surgery
Key Points In the thirty patients with aortic regurgitation in the Jupiter Postmarket Registry, initial device success of JenaValve implantation showed a high success rate of >95% with a device success rate of ∼89%. At one year transvalvar aortic gradients were an acceptable ∼13 mm Hg. Aortic regurgitation in patients in the Jupiter Postmarket Registry continued to be reduced at one‐year follow‐up with no/trace aortic regurgitation in 50% (though numbers are small). Patients with aortic regurgitation constitute a small number (∼10–15%) of patients with symptomatic aortic valve disease, and follow‐up numbers in the Jupiter Postmarket Registry are small (30 patients) with one year echo data in only 23 patients, making broad conclusions about JenaValve results for patients with aortic regurgitation problematic.